Clinical Trial: Precision Cancer Therapy in Rare Cancers
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Rare Malignant Neoplasm
Study Type: INTERVENTIONAL
Official Title: The MATRIX Clinical Studies of Precision Cancer Therapy for Rare Cancers
Brief Summary:
Some rare cancers are hard-to-treat and patients have a poor prognosis.It is known that some of these patients have targetable molecular alterations, and some benefit from targeted drugs.However in many cases these drugs are not approved for the rare cancers.In this study the aim is to do advanced molecular diagnostics to identify possible targets for therapy, and to treat accordingly.
Read more